about
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt ...
Read More
0.05
0.02
(66.67%)
413.0M
XNAS Volume
High volume+gain today
XNAS 06 Apr, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for IO Biotech Inc is scheduled for today, for the purpose of IO Biotech Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
IO Biotech Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..